Protective effect of curcumin on experimentally induced inflammation, hepatotoxicity and cardiotoxicity in rats: Evidence of its antioxidant property

Experimental and Toxicologic Pathology

Volumn 63, Issue 5, 2011, Pages 419-431

  Naik, Suresh R ^a   Thakare, Vishnu N ^b   Patil, Snehal R ^a  

^a PRIN K M KUNDNANI COLLEGE OF PHARMACY   (India)

^b Sinhgad Institute of Pharmaceutical Sciences   (India)

Author keywords

Antioxidants; Cardiotoxicity; Curcumin; Hepatotoxicity; Inflammation; Lipid peroxidation; Serum marker enzymes

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CURCUMIN; DICLOFENAC; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IRON; ISOPRENALINE; NITRIC OXIDE; SILYMARIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOTOXICITY; CATALYSIS; CONTROLLED STUDY; DRUG DOSE COMPARISON; FEMALE; GRANULOMA; HEART MUSCLE NECROSIS; HEART PROTECTION; HEART WEIGHT; HEMOLYSIS; HISTOPATHOLOGY; INFLAMMATION; LIPID PEROXIDATION; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; LIVER WEIGHT; MALE; NONHUMAN; PAW EDEMA; RAT;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BODY WEIGHT; CURCUMIN; DRUG-INDUCED LIVER INJURY; EDEMA; ERYTHROCYTES; FEMALE; GRANULOMA, FOREIGN-BODY; HEART; HEMOLYSIS; LIPID PEROXIDATION; LIVER; LIVER FUNCTION TESTS; MALE; MYOCARDIUM; NECROSIS; ORGAN SIZE; RATS; RATS, WISTAR;

ANIMALIA; GOSSYPIUM HIRSUTUM; RATTUS;

EID: 79955971155     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.03.001     Document Type: Article

References (58)

1. Abe Y., Hashimoto S., Horie T. Curcumin inhibition on inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharm Res 1999, 39:41-47.
2. Adolfs M.J., Bonta I.L., Bragt P.C. Increased lipid peroxidation and decreased hepatic aminopyrine metabolism during carrageenin-induced granulomatous inflammation in the rat. Br J Pharmacol 1980, 68:123-124.
3. Aggarwal B.B., Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009, 41:40-59.
4. Aggarwal B.B., Kumara A., Bharati A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003, 23:363-398.
5. Ammon H., Whal M.A. Pharmacology of Curcuma longa. Planta Med 1991, 57:1-7.
6. Ansari N.M., Bhandari U., Pillai K.K. Protective role of curcumin in myocardial oxidative damage induced by isoproterenol in rats. Hum Exp Toxicol 2007, 26:933-938.
7. Brouet I., Ohishima H. Curcumin an anti-tumor promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 1995, 206:533-540.
8. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of turmeric: Curcuma longa. J Alt Compl Med 2003, 9:161-168.
9. Chattopadhyay I., Biswas K., Bandopadhyay U., Banerjee R. Turmeric and curcumin: biological actions and medicinal applications. Curr Sci 2004, 87:44-53.
10. Devasagayan T.P., Boloor K.K., Ramasarma T. Methods for estimating lipid peroxidation: an analysis of merits and demerits. Ind J Biochem Biophys 2003, 40:300-308.
11. Dikshit M., Rastogi L., Shukla R., Srimal R.C. Prevention of ischemia induced biochemical changes by curcumin and qinidine in the cat heart. Ind J Med Res 1959, 101:31-35.
12. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys 1999, 82:70-72.
13. Fabinyl-Szebehely M., Hahn L., Szebehely S. Investigation in vivo new inhibitors of hyaluronidase. Br J Pharmacol 1953, 8:30-33.
14. Ignarro L.J. Lysosome membrane stabilization in vivo: effect of steroidal and nonsteroidal anti-inflammatory drugs on the integrity of rat liver lysosomes. J Pharmacol Exp Ther 1972, 182:179-188.
15. Jagetia G.C., Aggarwal B.B. 'Spicing up' of the immune system by curcumin. J Clin Immunol 2007, 27:19-25.
16. Khanna N.M. Turmeric - nature's precious gift. Curr Sci 1999, 76:1351-1356.
17. Kind P.R.N., King E.J. Estimation of plasma phosphatase by determination of hydrolyzed phenol with amino antipyrine. J Clin Pathol 1954, 7:322-328.
18. Kohli K., Ali J., Ansari M.J., Rahaman Z. Curcumin: a natural anti-inflammatory agent. Ind J Pharmacol 2005, 37:141-147.
19. Kunchandy E., Rao M.N. Mechanisms of cancer chemoprevention by curcumin. Intl J Pharm 1990, 38:239-240.
20. Kurup V.P., Barrios C.S., Raju R., Johnson B.D., Levy M.B., Fink J.N. Immune response modulation by curcumin in a latex allergy model. Clin Mol Allergy 2007, 5:1.
21. Kurup V.P., Barrios C.S. Immunomodulatory effects of curcumin in allergy (review). Mol Nutr Food Res 2008, 52:1031-1039.
22. Lee P.Y., Paul B., McCay I., Hornbrook K.R. Evidence for carbon tetrachloride-induced lipid peroxidation in mouse liver. Biochem Pharmacol 1982, 31:405-409.
23. Li L., Liu C., de Couto G., Quzounian M., Sun M., Wang A.B. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest 2008, 118:879-893.
24. Lil J.L., Santman F.W., Lardy H.A. Antioxidant enzyme systems in rat liver and skeletal muscle. Arch Biochem Biophys 1988, 263:150-160.
25. Litchfield JT, Wilcoxon F. A simple method of evaluating dose effect experiments. J Pharm Exp Ther 1949, 96:99-113.
26. Lohner K., Sen A.C., Prankerd R., Esser A.F., Perrin J.H. Effect of drug-binding on the thermal denaturation of human serum albumin. J Pharm Biomed Anal 1994, 12:1501-1505.
27. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein estimation with the Folino-phenol reagent. J Biol Chem 1951, 193:265-275.
28. Meister A. A new aspect of glutathione biochemistry and transport selective alterations of glutathione metabolism. Nutr Rev 1984, 42:397-400.
29. Michael D., Williams, Nadler J.L. Inflammatory mechanism of diabetic complication. Curr Diabetes Rep 2007, 7:242-248.
30. Morimoto T., Sunagawa Y., Kawamura T., Takaya T., Wada H., Nagasawa A. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 2008, 118:868-878.
31. Mortellini R., Foresti R., Bassi R., Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces hemeoxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 2000, 28:1303-1312.
32. Ohkawa H., Nobuko K. Assay of lipid peroxide in animal tissue by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
33. Paoletti R., Bolego C., Poli A., Cignarella A. Metabolic syndrome, inflammation and atherosclerosis. Vasc Health Risk Manage 2006, 2:145-152.
34. Park E.J., Jeon C.H., Ko G., Kim J., Sohn D.H. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J Pharm Pharmacol 2000, 52:437-440.
35. Penn G.B., Ashford A. The inflammatory response to implantation of cotton pellets in the rat. J Pharm Pharmacol 1963, 15:798-803.
36. Perez R.M., Perez S., Zavala M.A., Salazar M. Anti-inflammatory activity of the bark of Hippocratea excelsa. J Ethnopharmacol 1995, 47:85-90.
37. Recknagel R.O. A new direction in the study of carbon tetrachloride hepatotoxicity. Life Sci 1983, 33:403-408.
38. Reddy P., Lokesh B.R. Effect of dietary turmeric (Curcuma longa) on iron-induced lipid peroxidation in the rat liver. Food Chem Toxicol 1994, 32:279-283.
39. Reitman S., Frankel S. A colorimetric determination of serum. Glutamic oxaloacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957, 28:56-62.
40. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985, 17:291-306.
41. Roth H.J., Miller B. On the color reaction between boric acid and curcumin. I. Boric acid-curcumin complexes. Arch Pharm 1964, 297:617-623.
42. Rotruck J.T., Pope A.L., Ganther H.E., Hofeman D.G., Hoeksta W.G. Biochemical role as a component of glutathione peroxidase. Science 1973, 179:588-590.
43. Salahuddin A., Jeremy A., Charles J., Malemud, Tariq M.H. Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review. Evidence-based Complement Alt Med 2005, 2:301-308.
44. Saso L., Valentini G., Casini M.L., Grippa E., Gatto M.T., Leone M.G., et al. Inhibition of heat-induced denaturation of albumin by nonsteroidal anti-inflammatory drugs (NSAIDs): pharmacological implication. Pharmacol Toxicol Pharm 2001, 24:150-158.
45. Seo Kwon-II, Sook Choi-M, TuJung U., Jinkim H., Yeo J., Min J.S., et al. Effect of curcumin supplementation on blood glucose, plasma insulin and glucose homeostasis related enzyme activities in diabetic ab/db mice. Mol Nutr Food Res 2008, 52:995-1004.
46. Sharma R.A., Gescher A.J., Steward W.P. Curcumin: the story so far. Eur J Cancer 2005, 41:1955-1968.
47. Shoelson S.E., Herrero L., Naaz A. Obesity, inflammation and insulin resistance. Grastroenterology 2007, 132:2169-2180.
48. Silveski-IIiskovic N., Hill M., Chow D.A., Singhal P.K. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation 1995, 91:10-15.
49. Sinatra S.T., DeMarco J. Free radicals, oxidative stress, oxidized low-density lipoprotein (LDL), and the heart: antioxidants and other strategies to limit cardiovascular damage. Conn Med 1995, 59:579-588.
50. Sreejayan Rao MN. Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol 1997, 49:105-107.
51. Suchalata S., Shyamala Devi C.S. Protective effect of Terminalia chebula against experimental myocardial injury induced by isoproterenol. Ind J Exp Biol 2004, 42:174-178.
52. Sun M., Zigman S. An improved spectrophotometric assay for superoxide dismutase based on epinephrine auto oxidation. Anal Biochem 1978, 90:81-89.
53. Suzuki M., Nakamura T., Iyoki S., Fujiwara A., Watanabe Y., Mohri K., et al. Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. Biol Pharm Bull 2005, 28:1438-1443.
54. Tohda C., Nakayama N., Hatanka F., Komatsu K. Comparision of anti-inflammatory activities of six curcuma rhizomes: a possible curcuminoid-independent pathway mediated by Curcuma phaeocaulis extract. J Alt Compl Med 2006, 3:255-260.
55. Tosaki A., Engelman D.T., Pali T., Engelman R.M., Droy-Lefaix M.T. Ginkgo biloba extract (EGb-761) improves post ischemic function in isolated preconditioned working rat hearts coronary. Artery Dis 1994, 5:443-450.
56. Vojdani A., Erde J. Regulatory T cells, a potent immunoregulatory target for CAM researchers: the ultimate antagonist (I). Evidence-based Complement Alt Med 2006, 3:25-30.
57. Winter C.A., Risley E.A., Nuss G.W. Carrageenan induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962, 111:544-547.
58. Yadav V.S., Mishra K.P., Singh K.P., Mehrotra S., Singh V.K. Immunomodulatory effects of Curcumin. Immonopharmacol Immunotoxicol 2005, 27:485-497.